ValitaCell

ValitaCell

We create pioneering analytical technologies for quality control and performance for the biopharmaceutical industry.

Founded 2014 Ireland

Ireland 6 employees Grant Total: $4.03M Biotechnology, Health Care +1

ValitaCell is a biotechnology startup with a vision to revolutionize the biopharmaceutical industry through pioneering analytical technologies. Since its establishment in 2014, the company has been dedicated to creating and commercializing innovative products to enhance quality control and performance in the biopharmaceutical sector. Through its cutting-edge products, ValitaCell aims to expedite the introduction of novel medicines to the market, offering a more cost-effective and expedited process while ensuring regulatory adherence. The company's commitment to leveraging artificial intelligence further underscores its ambition to be at the forefront of biological science and cell therapy. The recent €2.03M grant investment secured by ValitaCell on 01 October 2017 from EASME - EU Executive Agency for SMEs attests to the promising prospects of the company and the confidence it has garnered from esteemed investors. As of now, ValitaCell has become a part of the Beckman Coulter Life Sciences company, further solidifying its position in the industry. Based in Ireland, ValitaCell operates at the intersection of biotechnology, health care, and medical devices, positioning itself as a key player in driving advancements within these domains. With its innovative approach and strategic partnerships, ValitaCell is poised to continue making significant contributions to the biopharmaceutical landscape.

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	€2.03M	1	EASME - EU Executive Agency for SMEs	01 Oct 2017
Venture Round	€2.00M	-		19 Jun 2017
Venture Round	Undisclosed	1	Enterprise Ireland	17 Nov 2016

Funding Stage

Amount

Investors

Lead Investors

Date

Grant

€2.03M

EASME - EU Executive Agency for SMEs

01 Oct 2017

Venture Round

€2.00M

19 Jun 2017

Venture Round

Undisclosed

Enterprise Ireland

17 Nov 2016

FAQ About ValitaCell

We create pioneering analytical technologies for quality control and performance for the biopharmaceutical industry.

ValitaCell was founded in 2014.

ValitaCell is headquartered in Ireland.

ValitaCell operates in Biotechnology, Health Care and Medical Devices. Its work centres on Biologics, Biopharmaceuticals, Bioprocessing and Cell therapy.

ValitaCell has approximately 6 employees.

ValitaCell has completed 3 funding rounds, raising a total of $4.03M. The latest funding stage is Grant.

Top alternatives and competitors to ValitaCell include Sistemic Ltd, Eureka Biotechnology Co., Limited, Samsung Biologics, Juventas Cell Therapy Corp., Wuhan Healthgen Biotechnology Corp.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

ValitaCell and Sistemic Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About ValitaCell

Funding Rounds & Investors (3)

ValitaCell Alternatives & Competitors

FAQ About ValitaCell